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Objective : The management of diffuse astrocytomas is one of the most controversial areas in clinical neurooncology. There
are numerous reviews and editorials outlining the difficulties in the management of these lesions. In this study, we assess
the role of Gamma Knife radiosurgery(GKS) for diffuse astrocytomas.
Methods : Twenty-three patients with a diffuse astrocytoma were treated with GKS as a primary or adjuvant method from
February 1995 to October 2003. The mean marginal dose was 13.6 (8.5~17.5)Gy and the mean maximal dose was 27.3 (17.0~
35.0)Gy. Local control and the pattern of radiologic response were evaluated. The probable factors affecting local control,
such as tumor volume, margin dose, previous history of craniotomy or stereotactic biopsy, and the presence or absence
of previous radiotherapy were statistically analyzed. The average duration of follow-up was 39.7 (11.3~101.5) months after GKS.
Results : Of the 23 lesions treated, 16 lesions (69.6%) were controlled during the follow-up period. The mean progression-
free interval was 57.4 months and the 5-year progression-free rate was 68%. Only tumor volume was found to be a statistically
significant factor for local control. Smaller tumors were better controlled by GKS; it was significantly effective in tumors with
less than a 10cm3 volume. 
Conclusion : GKS could be a valuable therapeutic modality both as a primary treatment and as a postoperative adjuvant
therapy in some selected cases. 
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Introduction
The management of diffuse astrocytomas is one of the mostcontroversial areas in clinical neurooncology. The the-
rapeutic options for diffuse astrocytomas include surgery,
radiotherapy, and even observation. Surgical strategies and
timing of treatment are also debatable matters15,26). There are
several studies regarding the use of radiosurgery for malignant
gliomas, however, there have only been a few reported series on
low grade gliomas8). The majority of these studies analyzed
both WHO grade I and II tumors9,13); however, the behavior
and prognosis of grade I and II gliomas are quite different.
We studied the possible role of Gamma Knife radiosurgery
(GKS) in the treatment of low grade gliomas, especially grade
II gliomas. This study included diffuse astrocytomas, which
were histologically confirmed by surgical resection or biopsy.
GKS was used as a primary treatment method for eloquently
located lesions and childhood lesions. For recurrent or residual
lesions, GKS was used as a palliative method after surgical
resection, with or without external radiotherapy. 
Materials and Methods
Patient selection 
Twenty-three patients with a diffuse astrocytoma were treated
with GKS from February 1995 to October 2003. There were
eight men and fifteen women, with a mean age of 28.3 (7.5~
57.9) years at the time of GKS. All tumors were histologically
confirmed as diffuse astrocytomas. Craniotomies and resections
were performed in eight cases, stereotactic biopsies in fourteen
cases, and open biopsy in one case. We excluded the cases which
were only radiologically diagnosed as a diffuse astrocytoma.
Pre-radiosurgical external radiation therapy was performed
in five cases; all of these lesions had been resected prior to
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external radiation. GKS was used as an adjunctive treatment
method for these lesions once they recurred. The other eighteen
patients who were not treated with external radiation had
radiologically discrete, small-volumed, and eloquently located
tumors. For these patients, GKS was used as a primary trea-
tment method. GKS was also performed as a primary treatment
for the seven patients less than 18 years of age.
Radiosurgical treatments 
The mean marginal dose was 13.6 (8.5~17.5)Gy and the
mean maximal dose was 27.3 (17.0~35.0)Gy. The mean tumor
volume was 14.9 (0.7~55100)mm3. Radiosurgical targets
included distinct lesions, seen as low signal areas in T1-weighted
magnetic resonance imaging(MRI) and high signal areas in
T2-weighted MRI. 
Follow-up and statistical analysis
The average follow-up duration was 39.7 (11.3~101.5) mo-
nths after GKS. MRI was used for follow-up approximately
every three to six months, or when new symptoms or signs
developed. The local control, pattern of radiologic response
and clinical response were evaluated. Local failure was defined
as tumor volume that expanded to 120% or more of pre-GKS
volume; in these cases, the tumor subsequently required su-
rgical resection. The probable factors affecting local control,
such as tumor volume, margin dose, previous history of cra-
niotomy or stereotactic biopsy, and the presence or absence
of previous radiotherapy were statistically analyzed using Cox
regression analysis (SPSS 11.0, p＜0.05). The survival and
progression-free interval were estimated using the Kaplan-
Meier method (SPSS 11.0). 
Results
Tumor locations and diagnostic methods 
There were a total of eight surgically resected lesions; five were
located at the cortex, and one each was located at the thalamus,
insula and mesial temporal lobe. Fifteen patients were diagnosed
by stereotactic biopsy. The tumors location were summarized
in Table 1. 
Tumor control and affecting factors
Of the 23 lesions, 16 (69.6%) were controlled during the
follow-up period; 9 had a static course and 7 regressed. Of the
7 lesions that were not controlled, 5 progressed and 2 recurred;
all resulted from local failure. After defining them as failures,
four patients were treated with craniotomy and tumor resection,
one patient was treated with external radiation therapy only
and two patients died from tumor progression at 16.9 and 34.5
months after GKS, respectively. 
Of the four patients treated with tumor resection, two patie-
nts were histologically diagnosed as malignant transformations.
One was a 28-year-old woman who had been treated with
tumor resection and diagnosed as diffuse astrocytoma. Three
years after resection, non-enhancing solid tumor recurred and
GKS was performed. A small enhancing lesion appeared at 19
months after GKS and this lesion was eventually resected at
31 months after GKS. The histologic diagnosis was malignant
astrocytoma. The other was a 35-year-old man. He had pr-
esented 2 times of generalized seizure and diagnosed low grade
Table 1. Tumor locations
Tumor location Number of patients
Thalamus, hypothalamus 6
Motor, speech area 6
Subcortex 4
Cortex 5
Brain stem 2
Fig. 2. Kaplan-Meier survival curve for progression-free interval. The
mean progression-free interval is 57.4 months, and the 2-year and
5-year progression-free rates are 68.0%.
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Fig. 1. Kaplan-Meier survival curve. The mean survival time is 91.2
months. Two-year and 5-year survival rates are 95.2% and 85.7%,
respectively.
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glioma. Six year after the first presentation, the lesion was
resected and diagnosed as diffuse astrocytoma. Eleven months
after craniotomy GKS was performed. The GKS treated lesion
went on growing and it was resected again. Histologic diagnosis
was mixed form of radiation necrosis and malignant astroc-
ytoma. Two patients treated with tumor resection after failure
were diagnosed as a diffuse astrocytoma mixed with radiation
necrosis, or fibrinous change and hyaline thickening of small
vessels consistent with radiation effects.   
The mean survival time was 91.2 months (95% confidence
interval 77.4~104.9). Two-year and 3-year survival rates were
95.2% and 85.7%, respectively. No patients died 3 years after
GKS (Fig. 1). The mean progression-free interval was 57.4
months. Two-year and 5-year progression-free rates were 68.0%
(Fig. 2). In 12 patients (52.1%), new symptoms occurred after
GKS. Neurological deterioration was observed in 9 patients;
7 with tumor recurrence, 2 with new cyst, and 1 with perit-
umoral edema. The neurological signs were transient in 3
patients with new cyst or peritumoral edema. Other newly
developed symptoms were transient seizure and headache due
to aggravated cyst or peritumoral edema.
With regards to factors affecting local control, we analyzed
tumor volume, margin doses, presence or absence of previous
radiation therapy, and previous tumor removal or stereotactic
biopsy. Among these factors, only tumor volume was statis-
tically significant (p＜0.05). Smaller tumors could be better
controlled by GKS, and especially those with a volume less
than 10cm3. Of the 13 cases with tumor volumes less than
10cm3, 2 (15.4%) failed local control, whereas 5 of the 10
cases (50.0%) with tumor volumes greater than 10cm3 failed
local control (p＜0.05).
Radiologic responses after GKS
On retrospective review of the treated lesions, 12 (52.2%)
patients showed postradiosurgical enhancements. Enhancement
with volume expansion was noted in 7 cases; 5 of these patients
eventually failed treatment. Enhancement without volume
change was noted in 2 cases and enhancement with volume
reduction in 3 cases. 
Volume enlargement always accompanied increased peritu-
moral edema. The degree of peritumoral edema was measured
by subtracting the maximal diameter(cm) of the tumor from
that of the peritumoral edema on the T2 weighted MR image.
Preradiosurgical edema was excluded. In 10 patients (43.5%),
the newly developed or aggravated peritumoral edema was
identified on follow-up MRI. However, in 6 patients, the pe-
ritumoral edema was related to tumor enlargement, and only
in 4 patients (17.4%), radiation-related edema were identified.
Only 2 patients were transiently symptomatic. The radiation-
related edema developed at a mean of 6.4 months (range 3.3
to 11.5 months) after GKS and was sustained for 15.5 months
(range 9.0 to 32.4 months).
Mass effect resulted from tumor volume enlargement mixed
with perilesional edema was direct cause of death in two pa-
tients. In other three patients who had the enhanced and
enlarged tumors and eventually failed treatment, tumor enl-
argement was 200 to 400% and new or additional edema was
3 to 5cm. All they were needed tumor resection with steroid
administration. Other radiologic findings included cysts in
4 patients; 3 of these patients needed cyst aspirations due to
transient cyst expansion, but the solid parts regressed progr-
essively. Progressive tumor reduction was evident in 5 of the 23
cases; of these, 2 disappeared completely and 1 recurred. Finally,
2 of the 23 cases never showed an imaging change (Table 2).
Illustrative Cases 
Case 1 
A 55 year-old male with a cortical lesion underwent a cranio-
tomy and tumor removal procedure with subsequent external
radiation, twice. On follow-up images, the gyrus was thickened
and was considered to be a recurrence. GKS was preformed
with a dose of 12.5Gy to the 50% margin. At eight months
post- GKS, the gyrus had shrunk (Fig. 3). 
Case 2 
A 9 year-old girl with a mesial temporal tumor had an episode
of generalized tonic-clonic seizure. The lesion was confirmed
as a diffuse astrocytoma by stereotactic biopsy. GKS with a
marginal dose of 14Gy was performed as a primary treatment.
At ten months after radiosurgery, the tumor was enhanced, but
not combined with volume expansion. At the twenty-two
month follow-up, the lesion has remained static, without fu-
rther change (Fig. 4).
Case 3 
This 12 year-old girl had a non-enhancing precuneus mass;
its pathology was a diffuse astrocytoma confirmed by stere-
otactic biopsy. GKS was done with a margin dose of 14Gy.
Table 2. Radiologic responses after gamma knife radiosurgery 
Post-GKS response Number of patients Failures
Enhancement 12 6
with increased volume 7 5
without volume change 2 1
with decreased volume 3 0
New cyst 2* -
Cyst progression 2* -
Progressive reduction 5 1
No change 2 -
*Three patients needed cyst aspirations due to transient cyst expansions, however
solid parts regressed progressively
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Fig. 3. A : Precontrast brain magnetic resonance(MR) imaging showing
a low signal lesion on the right temporal cortex after resection and
external radiation. B : Precontrast MR image, 28 months later, showing
gyral thickening, which is considered a recurrence. C : T1-weighted MR
image on the day of Gamma Knife radiosurgery(GKS). D : Eight months
after GKS, follow-up MR image showing significant gyral shrinkage.
A B
C D
Fig. 4. A : T2-weighted magnetic resonance MR imaging showing a
non-enhancing lesion in the left mesial temporal area. B : T1-weighted
enhanced MR image at the time of Gamma Knife radiosurgery(GKS)
showing a signal defect due to previous stereotactic biopsy. C : Tumor
is enhanced 10 months after GKS. D : No significant change on MR
image 22 months after GKS.
During follow-up, the lesion showed enhancement and prog-
ressive volume expansion. The lesion needed resection thirteen
months after GKS (Fig. 5). Pathologic diagnosis was diffuse
astrocytoma and radiation necrosis. 
Discussion
Radiosurgery for diffuse astrocytomas
Glial tumors can have an infiltrative margin and a heteroge-
neous pathologic spectrum within one tumor; it has therefore
been arguable to treat gliomas by stereotactic radiotherapy or
radiosurgery15). Although there have been several studies on
radiosurgery of glial tumors, most are about malignant gliomas.
There are few reports about WHO grade II gliomas2,4,13). Kida
et al.13) reported results of GKS for 51 patients with low grade
gliomas. For a mean follow-up period of 27.6 months, the
control rate of grade I tumors was 91.7% and that of grade II
was 87.2%. All patients received GKS as a primary treatment
because the majority of their tumor location was near the optic
nerve or hypothalamus. They used a prescription dose of 15.7
Gy for grade II tumors and noted a high rate of radiation-
induced edema. They did not discuss the favorable factors for
tumor control. Chun et al.4) reported results of 17 patients with
low grade gliomas treated with GKS for a mean follow-up of
7.6 years. In their report, using a mean margin dose of 18.2Gy,
the tumor control rate was 52.9% and the postradiosurgical
complication rate was 58.8%. They discussed the effects of
tumor volume and tumor control; in volumes less than or
greater than 10cm3, the control rate was 72.7% and 33.3%,
respectively. Sarkar et al.25), studied survival rates after GKS
on oligodendrogliomas or mixed oligoastrocytomas. They
concluded that the survival rate was improved in younger
patients and in patients with smaller tumors.
In the current study, the tumor control rate was 65.2% at
39.7 months. Considering we had a progression-free interval
of 57.4 months, Chun et al.’s poor results4) may come from
their longer follow-up duration. 
Regarding complications, radiation-related edema or necrosis
was considered as local failure in our series. The discrimination
between radiation necrosis and tumor recurrence or malignant
transformation is not always feasible, even with advanced im-
aging techniques. Actually, there are many cases with mixed
lesions of radiation necrosis and tumor recurrence7,10,11). Th-
erefore, it seems reasonable to count lesions that need to be
removed as a failure rather than a complication. The high
complication rate of Chun et al.’s series4) was related to high
doses. The proper dose between tumor control and adverse
effects needs to be further determined with clinical trials. 
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Radiotherapy and radiosurgery for diffuse astrocytomas
Radiotherapy has played a role in the treatments of low grade
gliomas, even if its benefit remains controversial. Mansur et
al.17) evaluated the progression-free survival in 21 patients with
grade II gliomas treated with surgery and adjuvant radioth-
erapy. The median time to progression was 31.4 months and
the 5-year progression-free survival rate was 51%. Although
the direct comparison between fractionated radiotherapy and
radiosurgery is not appropriate, the results are comparable to
ours. In addition to radiotherapy controversies, a variety of
treatments using radiation have been tried for gliomas, such as
frameless stereotactic radiotherapy3,24), interstitial radiosurg-
ery16,28), interstitial brachytherapy18), and intensity-modulated
conformal therapy12,19). The proper methodology should be
decided, but the current opinion is that stereotactic radiosu-
rgery is advantageous for small and discrete lesions, because
treatment planning in the conformation of high isodose lines
with the target volume is favorable. It provides a steeper dose
gradient outside the target volume and, therefore, a lower to-
xicity in normal tissue19). Moreover, serious side effects such
as mental retardation, endocrine dysfunctions, or cognitive
dysfunctions have been reported after radiotherapy in child-
hood5,6,15). Radiosurgery may play a role in selective cases of
gliomas, with minimizing the neurological sequelae, especially
in growing children.  
Postradiosurgical radiologic responses 
With regards to post-GKS radiologic response, 12 of 23
patients showed solid enhancement in their follow-up imaging
study; 6 of these, who also had increased tumor volume, failed
to be successfully treated. Postradiosurgery enhancement or
transient volume expansion is a known phenomenon in int-
racranial tumors3,20). Enhancement is known to be related to
irradiated endothelium; the concurrent production of large
numbers of abnormal endothelial cells disrupts microcirculation
and results in a breakdown of the blood-brain barrier1,23).
According to the given doses, the enhancement may represent
tissue injury and gliosis or tissue loss22). In our cases, surgically
extirpated enhancing lesions turned out to be malignant tr-
ansformations in 2 patients and mixed diffuse astrocytoma
with radiation-induced tissue reactions in 2 patients. Although
the meaning of volume enlargement and enhancement remains
unknown, these responses need close follow-up as well as proper
management. 
Of the 4 cases with cysts, 1 had a static course; the other
three cysts enlarged. The cysts were treated with stereotactic
aspirations and Ommaya reservoir insertions. The mechanism
of post-GKS cyst formation or enlargement, remains unclear
and multiple factors, such as radiation-induced ischemic necro-
sis, increased vascular permeability or intratumoral hemorrhage
may be involved14,27). However, if the combined solid parts are
responsive to radiosurgery, the cysts can be controlled with as-
piration, as in our cases. 
Conclusion
GKSseems to be an appropriate alternative or primarytherapeutic modality in the treatment of WHO grade
II gliomas especially in small, well-demarcated, or deeply lo-
cated tumors, or in childhood tumors. Post-radiosurgery en-
hancement with volume enlargement may mean a local failure.
Cystic tumor has a tendency to increase in size after GKS and
close follow-up is needed. However, if cystic enlargement does
not accompany enlargement of the solid portion, possibility
of long-term control still exists. 
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Commentary
This paper is a very interesting article that can establish anew therapeutic modality to treat progressing low grade
astrocytoma using Gamma knife radiosurgery(GKS) and we
got much encouraged. The effectiveness of conventional ra-
diation therapy in the management of low grade astrocytoma
is still controversial and under discussion. Furthermore, there
are serious complications of radiation therapy including acute
cerebral edema and long-term and delayed neurotoxicity such as
neurocognitive defects, cystic formation and radiation necrosis.
Recently, Plathow et al3) reported that stereotactic radiot-
herapy is effective and low toxicity in the treatment of low
grade gliomas compared with after conventional radiotherapy.
In addition, Marcus et al2) suggested that stereotactic radio-
therapy provides excellent local control for children with
small, localized low grade glial tumors. Therefore, GKS also
may be a valuable treatment modality in selected cases of
low grade glioma. According to this paper, tumor control rate
and 5-year progression free rate is about 70% after GKS in
low grade astrocytomas, and especially effective in tumor with
small tumor volume.
To get optimal therapeutic response after GKS in low grade
astrocytoma, we should determine not only indication criteria
such as size, location, peritumoral edema, cystic change, ne-
urological deficit and age but also optimal timing of GKS. Also,
in GKS, physician should establish optimal radiation dose
and extent of radiosurgery through further studies1). In order
to reduce complication of radiosurgery and elevate the efficiency
by use of GKS, effective radiation dose and more strict extent
of irradiation with widely acceptable imaging modality such
as T2 weighted MR imaging. Additionally, there is the hope
that comparison of results with other therapeutic modalities
and prognosticators such as extent of enhanced mass, radiation
dose, gender and age should be established and long term
follow-up is needed.
Seung-Hoon Lee, M.D.
Department of Neurosurgery, National Cancer Center
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